SUTRO BIOPHARMA, INC. Increase (Decrease) in Deferred Revenue
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-11-14
- 2018-09-30: Increase (Decrease) in Deferred Revenue 9 month $49.17M.
- 2017-09-30: Increase (Decrease) in Deferred Revenue 9 month -$22.88M.
| Period end | Increase (Decrease) in Deferred Revenue 9 month |
|---|---|
| 2018-09-30 | $49.17M 10-Q · filed 2018-11-14 |
| 2017-09-30 | -$22.88M 10-Q · filed 2018-11-14 |